Overview
In Switzerland, peptides are not treated as a single legal category: peptide-based medicines (such as GLP-1 weight-loss drugs and hormone-type peptides) are regulated as medicinal products under the Therapeutic Products Act and require Swissmedic authorisation and a doctor's prescription, while collagen-type peptide supplements and cosmetics are sold legally over the counter. So-called 'research' or performance peptides (e.g. BPC-157, TB-500, growth-hormone-related peptides) sold online generally have no Swiss marketing authorisation and are treated either as unauthorised medicinal products by Swissmedic or as doping agents by Swiss Sport Integrity, and shipments are intercepted at the border. In June 2026 Swissmedic, the Federal Office for Customs and Border Security and Swiss Sport Integrity ran a joint enforcement campaign specifically targeting illegally imported peptides. Personal, non-commercial imports in very small quantities may still be released by customs, so the practical picture is restriction and active enforcement rather than a blanket ban on every peptide-containing product.
Key Points
- Peptide medicines fall under Switzerland's Federal Act on Medicinal Products and Medical Devices (Therapeutic Products Act, TPA; SR 812.21), which is the core statute administered by Swissmedic. [5]
- Prescription peptide medications, such as those used for diabetes and weight loss, cancers and hormone conditions, are available in Switzerland only on a doctor's prescription, whereas peptide powders, pills and collagen-derived skincare products are widely and legally sold over the counter as supplements. [4]
- Swiss pharmacies may compound peptides only when they are prescribed by a doctor and only using raw materials approved by Swissmedic, which rules out compounding from unapproved 'research' peptide powders. [4]
- On 22 June 2026 Swissmedic, together with the Federal Office for Customs and Border Security and Swiss Sport Integrity, ran a cross-agency targeted campaign against illegally imported peptides, checking 46 packages of dubious peptide-based preparations and retaining 23 of them, of which 21 were classified as doping agents and two as medicinal products. [1]
- In that operation the other 23 consignments had to be released despite the identified health risks because the quantities involved fell below the applicable threshold, illustrating that small personal-use quantities are not always seized. [3]
- Swissmedic's stated position is that these online peptide products come from uncontrolled manufacturers or suppliers, that some substances have never been tested in humans so that people injecting them are effectively test subjects, and that contaminants absent from authorised originals have already been detected. [6]
- Swissmedic has separately warned the public against buying falsified versions of the semaglutide-class weight-loss product Ozempic. [7]
- No Swiss statute or ordinance creating a peptide-specific schedule or a named list of substances such as BPC-157 or TB-500 was located in this research, and the exact quantity limit for duty-free personal importation of medicines was not verified against a primary customs or Swissmedic source; the personal-import point above therefore reflects reporting on a single enforcement action rather than the text of the rule. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)